Here to help break down this new painkiller is Dr. Sean Mackey. He’s a Professor of Anesthesiology and Medicine at Stanford ...
Meet suzetrigine, a non-opioid that promises to avoid addiction risk. But some experts say it can't replace opioids ...
One participant in the drug trial for Journavx said it eliminated her pain without making her feel loopy or nauseous, which ...
The Food and Drug Administration approved Vertex Pharmaceuticals’ “Journavx” on Thursday, greenlighting the non-opioid ...
A study from Emory University suggests that an anti-inflammatory drug called ketorolac might help stop cancer metastasis if ...
Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...
A new type of non-opioid painkiller, aimed at treating short-term pain in adults, has been approved by the US Food and Drug Administration (FDA). The drug suzetrigine, known by its brand name Journavx ...
New Scientist on MSN6d
Using common painkiller in pregnancy might raise ADHD risk in childrenChildren may have a higher risk of developing ADHD if their mothers used paracetamol – also known as acetaminophen – during ...
A new study from the University of Washington suggests that using acetaminophen (also known as paracetamol) during pregnancy ...
Stop me if you’ve heard this one before: A miracle new painkiller promises to save us all from the scourge of addiction while effectively treating acute and perhaps even chronic pain.
The drug, shown to be almost as effective as opioids for short-term pain, is the first fundamentally new kind of painkiller to win FDA approval in more than 20 years.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback